Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma [4]

Gut

Volumn 54, Issue 11, 2005, Pages 1661-1662

  McWilliams, R ^a   Highsmith, W E ^a   Rabe, K G ^a   De Andrade, M ^a   Tordsen, L A ^a   Holtegaard, L M ^a   Petersen, G M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

CANCER RISK; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; HETEROZYGOTE; HUMAN; LETTER; ONSET AGE; PANCREAS ADENOCARCINOMA; PANCREATITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SAMPLING;

ADENOCARCINOMA; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 27444439642     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.074534     Document Type: Letter

References (10)

1. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-52.
2. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328:1433-7.
3. Holly EA, Eberle CA, Bracci PM. Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol 2003;158:432-41.
4. Silverman DT. Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen 2001;21:7-25.
5. Davis TM, Sawicka EH. Adenocarcinoma in cystic fibrosis. Thorax 1985;40:199-200.
6. McIntosh JC, Schoumacher RA, Tiller RE. Pancreatic adenocarcinoma in a patient with cystic fibrosis. Am J Med 1988;85:592.
7. Sheldon CD, Hodson ME, Carpenter LM, et al. A cohort study of cystic fibrosis and malignancy. Br J Cancer 1993;68:1025-8.
8. Neglia JP, FitzSimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995;332:494-9.
9. Malats N, Casals T, Porta M, et al. Cystic fibrosis transmembrane regulator (CFTR) deltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut 2001;48:70-4.
10. Matsubayashi HFN, Sato N, Brune K, et al. Polymorphisms of SPINKI N34S and CFTR in Patients with Sporadic and Familial Pancreatic Cancer. Cancer Biol Tner 2003;2:652-5.